SEARCH RESULT

Total Matching Records found : 273

MS Swaminathan, father of Green Revolution, interviewed by Jitheesh PM & Jipson John (Newsclick.in)

-Newsclick.in In an interview, the ‘father’ of India’s Green Revolution, says while technology is necessary, policies on procurement and public distribution are far more important in making agriculture economically viable and sustainable in the country. No one has played a more instrumental role in India’s self-sufficiency in food production than Dr MS Swaminathan — world-renowned agricultural scientist, known as the ‘Father of Green Revolution in India’. After getting a PhD from Cambridge...

More »

To shield patents, firms seek information on generic drug launches -Sushmi Dey

-The Times of India NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval. The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking...

More »

Centre bans 328 combination drugs in setback for pharma companies

-PTI The president of the Indian Drug Manufacturers' Association said the order would have an impact on a market worth an estimated 16 billion rupees a year for such drugs, which are produced by both small and large pharma companies. New Delhi: The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but the ban has been cheered by health activists worried about growing...

More »

Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel

-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...

More »

The tightrope walk of India's drug-price regulator -Anuj Gupta

-The Economic Times The genesis: The National Pharmaceutical Pricing Authority (NPPA) was set up to implement the 1995 Drug Price Control Order (DPCO) and monitor overcharging of drugs and medical devices When: August 29, 1997 Total number of chairmen: 11 What the chairman has to deliver: * Implement and enforce the provisions of the DPCO * Render advice to the central government on drug pricing Highlights of the chairmen's tenures * Between 2001 and 2004, five chairmen were...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close